Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies

NCT01967043 is registered in ClinicalTrials.gov with Kinex Pharmaceuticals Inc. as lead sponsor.

NCT NCT01967043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01967043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies
Lead sponsor
Kinex Pharmaceuticals Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
September 30, 2016
Enrollment
34 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor